These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 28082152)
1. Pharmacogenomics in epilepsy. Balestrini S; Sisodiya SM Neurosci Lett; 2018 Feb; 667():27-39. PubMed ID: 28082152 [TBL] [Abstract][Full Text] [Related]
2. Role of Pharmacogenomics in Antiepileptic Drug Therapy: Current Status and Future Perspectives. Gambardella A; Labate A; Mumoli L; Lopes-Cendes I; Cendes F Curr Pharm Des; 2017; 23(37):5760-5765. PubMed ID: 28891449 [TBL] [Abstract][Full Text] [Related]
3. The pharmacogenomics of epilepsy. Franco V; Perucca E Expert Rev Neurother; 2015 Oct; 15(10):1161-70. PubMed ID: 26327193 [TBL] [Abstract][Full Text] [Related]
4. The pharmacogenomics of valproic acid. Zhu MM; Li HL; Shi LH; Chen XP; Luo J; Zhang ZL J Hum Genet; 2017 Dec; 62(12):1009-1014. PubMed ID: 28878340 [TBL] [Abstract][Full Text] [Related]
5. Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies. Garcia-Rosa S; de Freitas Brenha B; da Rocha VF; Goulart E; Silva Araujo BH Curr Neuropharmacol; 2021; 19(6):813-831. PubMed ID: 32933463 [TBL] [Abstract][Full Text] [Related]
6. Update on pharmacogenetics in epilepsy: a brief review. Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995 [TBL] [Abstract][Full Text] [Related]
7. The potential of pharmacogenetics in the treatment of epilepsy. Depondt C Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088 [TBL] [Abstract][Full Text] [Related]
8. [Personalized medicine for epilepsy based on the pharmacogenomic testing]. Yoshida S; Sugawara T; Nishio T; Kaneko S Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631 [TBL] [Abstract][Full Text] [Related]
9. The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics. Holmes GL Epilepsy Res; 2002 Jun; 50(1-2):41-54. PubMed ID: 12151116 [TBL] [Abstract][Full Text] [Related]
10. A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy. Naimo GD; Guarnaccia M; Sprovieri T; Ungaro C; Conforti FL; Andò S; Cavallaro S Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366017 [TBL] [Abstract][Full Text] [Related]
11. Various pharmacogenetic aspects of antiepileptic drug therapy: a review. Mann MW; Pons G CNS Drugs; 2007; 21(2):143-64. PubMed ID: 17284096 [TBL] [Abstract][Full Text] [Related]
12. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview. Ferraro TN; Buono RJ Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945 [TBL] [Abstract][Full Text] [Related]
13. The role of common variation in drug transporter genes in refractory epilepsy. Soranzo N; Goldstein DB; Sisodiya SM Expert Opin Pharmacother; 2005 Jul; 6(8):1305-12. PubMed ID: 16013981 [TBL] [Abstract][Full Text] [Related]
14. Management of genetic epilepsies: From empirical treatment to precision medicine. Striano P; Vari MS; Mazzocchetti C; Verrotti A; Zara F Pharmacol Res; 2016 May; 107():426-429. PubMed ID: 27080588 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in epilepsy genetics. Orsini A; Zara F; Striano P Neurosci Lett; 2018 Feb; 667():4-9. PubMed ID: 28499889 [TBL] [Abstract][Full Text] [Related]
16. Genetics of antiepileptic drug resistance. Sisodiya SM; Marini C Curr Opin Neurol; 2009 Apr; 22(2):150-6. PubMed ID: 19532038 [TBL] [Abstract][Full Text] [Related]
17. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications. Depondt C; Shorvon SD Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898 [TBL] [Abstract][Full Text] [Related]
19. The clinical impact of pharmacogenetics on the treatment of epilepsy. Löscher W; Klotz U; Zimprich F; Schmidt D Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics in the treatment of epilepsy. Clancy CE; Kass RS Pharmacogenomics; 2003 Nov; 4(6):747-51. PubMed ID: 14596638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]